Where You May Obtain a Prospectus
Geron is distributing the shares of Asterias Series A common stock pursuant to a registration statement on Form S-1 , File No. 333-187706 (the "Registration Statement"), filed by Asterias under the U.S. Securities Act of 1933, as amended. The Registration Statement and the prospectus included therein (the "Prospectus") contain important information about Asterias, the Asterias Series A common stock. You should read the Registration Statement and the Prospectus carefully, including the Risk Factors section of the Prospectus. The Registration Statement and a final Prospectus, which may be amended from time to time, are available at the website maintained by the Securities and Exchange Commission at http://www.sec.gov or may be obtained from Asterias upon request to Asterias' Chief Financial Officer at 230 Constitution Drive, Menlo Park, CA 94025 or contacting their investor relations representative at (650) 433-2992 or InvestorRelations@asteriasbio.com.
The foregoing information shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Asterias, nor shall there be any sale of any Asterias Series A common stock securities in any state or other jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
Statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for Asterias, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statement
|SOURCE Asterias Biotherapeutics, Inc.|
Copyright©2014 PR Newswire.
All rights reserved